secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2022-09-07T23:59:59+00:00
Accession:  0001193125-22-239512
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics names new CFO and CMO; CFO Canepa resigns effective Sept 21
-------------------------------------------------------------------------------

- CFO John Canepa resigned effective Sept 21, 2022, to pursue other interests.
- Jason Amello appointed CFO effective Sept 21, 2022; base salary $460K, target bonus 40%.
- Garrett Nichols, MD, MS, appointed CMO effective Sept 12, 2022.
- Amello brings experience from Saniona, Akebia, Genzyme; Nichols from Istari, GSK.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/0001193125-22-239512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522239512/d352591d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-239512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer